Exocrine and endocrine modulation in common gastric carcinoma

American Journal of Clinical Pathology

Volumn 137, Issue 5, 2012, Pages 712-721

  Canzonieri, Vincenzo ^a   Colarossi, Cristina ^b   Del Col, Laura ^a   Perin, Tiziana ^a   Talamini, Renato ^a   Sigon, Roberto ^a   Cannizzaro, Renato ^a   Aiello, Eleonora ^b   Buonadonna, Angela ^a   Italia, Fabrizio ^c   Massi, Daniela ^d   Carbone, Antonino ^a   Memeo, Lorenzo ^b  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b Mediterranean Institute of Oncology   (Italy)

^c Oncopath Lab   (Italy)

^d UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Endocrine differentiation; Endocrine phenotype; Exocrine phenotype; Gastric carcinoma; Neuroendocrine differentiation; Prognosis

Indexed keywords

CHROMOGRANIN A; SYNAPTOPHYSIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MATURELY DIFFERENTIATED ENDOCRINE GASTRIC PHENOTYPE; MATURELY DIFFERENTIATED EXOCRINE GASTRIC PHENOTYPE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CARCINOMA; TUMOR CELL; TUMOR DIFFERENTIATION; ADENOCARCINOMA; CARCINOMA; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; STOMACH TUMOR;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CHROMOGRANIN A; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; STOMACH NEOPLASMS; SYNAPTOPHYSIN; TUMOR MARKERS, BIOLOGICAL;

EID: 84862604087     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPM13KVNCZQBUV     Document Type: Article

References (32)

1. Ferlay J, Shin HR, Bray F, et al. GLOBOCAN 2008. v1.2. Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. http://globocan.iarc.fr. Accessed July 1, 2011.
2. Shibata A, Parsonnet J. Stomach cancer. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer Epidemiology and Prevention. 3rd ed. New York, NY: Oxford University Press; 2006:707-720.
3. Foukakis T, Lundell L, Gubanski M, et al. Advances in the treatment of patients with gastric adenocarcinoma. Acta Oncol. 2007;46:277-285. (Pubitemid 46625031)
4. Tatematsu M, Tsukamoto T, Mizoshita T. Role of Helicobacter pylori in gastric carcinogenesis: the origin of gastric cancers and heterotopic proliferative glands in Mongolian gerbils. Helicobacter. 2005;10:97-106. (Pubitemid 40477017)
5. Blumenfeld W, Chandohoke DK, Sagerman P, et al. Neuroendocrine differentiation in gastric adenocarcinomas: an immunohistochemical study. Arch Pathol Lab Med. 1996;120:478-481. (Pubitemid 26157176)
6. Park JG, Choe GY, Helman LJ, et al. Chromogranin-A expression in gastric and colon cancer tissues. Int J Cancer. 1992;51:189-194.
7. Sentani K, Oue N, Noguchi T, et al. Immunostaining of gastric cancer with neuroendocrine differentiation: Reg IV-positive neuroendocrine cells are associated with gastrin, serotonin, pancreatic polypeptide and somatostatin. Pathol Int. 2010;60:291-297.
8. Waldum HL, Aase S, Kvetnoi I, et al. Neuroendocrine differentiation in human gastric carcinoma. Cancer. 1998;83:435-444. (Pubitemid 28354498)
9. Yao G, Zhou J, Lai M, et al. Neuroendocrine markers in adenocarcinomas: an investigation of 356 cases. World J Gastroenterol. 2003;9:858-861. (Pubitemid 36531576)
10. Takenaka Y, Tsukamoto T, Mizoshita T, et al. Gastric and intestinal phenotypic correlation between exocrine and endocrine components in human stomach tumors. Histol Histopathol. 2007;22:273-284. (Pubitemid 46117113)
11. Volante M, Rindi G, Papotti M. The grey zone between pure (neuro)endocrine and non-(neuro)endocrine tumours: a comment on concepts and classification of mixed exocrineendocrine neoplasms. Virchows Arch. 2006;449:499-506. (Pubitemid 44722317)
12. Jiang SX, Mikami T, Umezawa A, et al. Gastric large cell neuroendocrine carcinomas: a distinct clinicopathologic entity. Am J Surg Pathol. 2006;30:945-953. (Pubitemid 44264942)
13. Bordi C, Falchetti A, Azzoni C, et al. Aggressive forms of gastric neuroendocrine tumors in multiple endocrine neoplasia type I. Am J Surg Pathol. 1997;21:1075-1082. (Pubitemid 27407292)
14. Matsui K, Jin XM, Kitagawa M, et al. Clinicopathologic features of neuroendocrine carcinomas of the stomach: appraisal of small cell end large cell variants. Arch Pathol Lab Med. 1998;122:1010-1017. (Pubitemid 28521049)
15. Rindi G, Bordi C, Rappel S, et al. Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behaviour. World J Surg. 1996;20:168-172. (Pubitemid 26069482)
16. Tajima Y, Shimoda T, Nakanishi Y, et al. Gastric and intestinal phenotypic marker expression in gastric carcinomas and its prognostic significance: immunohistochemical analysis of 136 lesions. Oncology. 2001;61:212-220. (Pubitemid 34701536)
17. Hamilton SR, Aaltonen LA, eds. Pathology and Genetics of Tumours of the Digestive System. Lyon, France: IARC Press; 2000.
18. Sobin LH, Gospodarowicz MK, Wittekind C. TNM Classification of Malignant Tumours. 7th ed. Hoboken, NJ: Wiley-Blackwell; 2009.
19. Berretta M, Cappellani A, Di Vita M, et al. Biomarkers in neuroendocrine tumors. Front Biosci (Schol Ed). 2010;2:332-342.
20. Armitage P, Berry G, Matthews JNS. Statistical Methods in Medical Research. 4th ed. Oxford, England: Blackwell Science; 2002.
21. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
22. Ooi A, Mai M, Ogino T, et al. Endocrine differentiation of gastric adenocarcinoma: the prevalence as evaluated by immunoreactive chromogranin A and its biologic significance. Cancer. 1988;62:1096-1104.
23. Karam SM, Straiton T, Hassan WH, et al. Defining epithelial cell progenitors in the human oxyntic mucosa. Stem Cells. 2003;21:322-336. (Pubitemid 36623174)
24. Syder AJ, Karam SM, Mills JC, et al. A transgenic mouse model of metastatic carcinoma involving transdifferentiation of a gastric epithelial lineage progenitor to a neuroendocrine phenotype. Proc Natl Acad Sci U S A. 2004;101:4471-4476. (Pubitemid 38437435)
25. Fukuda K, Saikawa Y, Ohashi M, et al. Tumor initiating potential of side population cells in human gastric cancer. Int J Oncol. 2009;34:1201-1207.
26. Takaishi S, Okumura T, Tu S, et al. Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells. 2009;27:1006-1020.
27. Tajima Y, Yamazaki K, Nishino N, et al. Gastric and intestinal phenotypic marker expression in gastric carcinomas and recurrence pattern after surgery: immunohistochemical analysis of 213 lesions. Br J Cancer. 2004;91:1342-1348. (Pubitemid 39424796)
28. Kabashima A, Takashi Y, Sugimachi K, et al. Relation between biologic behavior and phenotypic expression in intramucosal gastric carcinomas. Hum Pathol. 2002;33:80-86. (Pubitemid 34112955)
29. Shibata N, Watari J, Fujiya M, et al. Cell kinetics and genetic instabilities in differentiated type early gastric cancers with different mucin phenotype. Hum Pathol. 2003;34:32-40. (Pubitemid 36160019)
30. Yamazaki K, Tajima Y, Makino R, et al. Tumor differentiation phenotype in gastric differentiated-type tumors and its relation to tumor invasion and genetic alterations. World J Gastroenterol. 2006;12:3803-3809. (Pubitemid 44028389)
31. Tajima Y, Shimoda T, Nakanishi Y, et al. Association of gastric and intestinal phenotypic marker expression of gastric carcinomas with tumor thymidylate synthase expression and response to postoperative chemotherapy with 5-fluorouracil. J Cancer Res Clin Oncol. 2003;129:683-690. (Pubitemid 38002299)
32. Peters GJ, Backus HHJ, Freemantle S, et al. Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism. Biochim Biophys Acta. 2002;1587:194-205. (Pubitemid 34655788)